Trials / Unknown
UnknownNCT03009721
Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia
A Non-interventional, Multi-center, Retrospective Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia (ROSE Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,707 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effectiveness and safety of Olostar Tab in patients with essential hypertension and dyslipidemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Other: Not applicable-observational study |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2017-01-04
- Last updated
- 2017-01-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03009721. Inclusion in this directory is not an endorsement.